AndzonBio2 Strengthens Scientific and Strategic Capabilities with New Advisory Board and Leadership Appointment.
Paris, February 3, 2026 – AndzonBio2, a biotechnology company focused on developing innovative therapeutic programs in neuroinflammation, today announced the formation of its Scientific Advisory Board (SAB), comprised of leading experts in neuroscience, neurodegeneration, drug discovery, and translational development. The…
